Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer. - Wikidata - wikimedia - TriplyDB

Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer.

Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer.

http://www.wikidata.org/entity/Q33331462

about

Translating genomic profiling to gastrointestinal cancer treatment.Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer.Clinicopathological significance of platelet-derived growth factor (PDGF)-B and vascular endothelial growth factor-A expression, PDGF receptor-β phosphorylation, and microvessel density in gastric cancer.Prognostic significance of vascular endothelial growth factor expression in gastric carcinoma: a meta-analysis.Anti-angiogenic therapies for advanced esophago-gastric cancer TEM7 (PLXDC1), a key prognostic predictor for resectable gastric cancer, promotes cancer cell migration and invasion.Dietary glycemic load and gastric cancer risk in Italy Pro-apoptotic and migration-suppressing potential of EGCG, and the involvement of AMPK in the p53-mediated modulation of VEGF and MMP-9 expression.Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma.Cross-talk between HIF and p53 as mediators of molecular responses to physiological and genotoxic stresses.Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma.Meta-analysis of immunohistochemical expression of hypoxia inducible factor-1α as a prognostic role in gastric cancer.An insertion/deletion polymorphism within the proximal promoter of EGLN2 is associated with susceptibility for gastric cancer in the Chinese population.Prognostic value of HIF-1α expression in patients with gastric cancer.Ramucirumab for gastric cancer.Angiogenesis inhibitors in gastric and gastroesophageal junction cancer.Gastric Cancer and Angiogenesis: Is VEGF a Useful Biomarker to Assess Progression and Remission?Canstatin induces apoptosis in gastric cancer xenograft growth in mice through the mitochondrial apoptotic pathway.Anti-tumor effect of the mammalian target of rapamycin inhibitor everolimus in oral squamous cell carcinoma.Novel Targeted Therapies for Esophagogastric Cancer.The increased expression of DEC1 gene is related to HIF-1α protein in gastric cancer cell lines.Occult gastric cancer presenting as hypoxia from pulmonary tumor thrombotic microangiopathy.The relative efficacy and safety of targeted agents used in combination with chemotherapy in treating patients with untreated advanced gastric cancer: a network meta-analysis.Overexpression and immunosuppressive functions of transforming growth factor 1, vascular endothelial growth factor and interleukin-10 in epithelial ovarian cancer.Angiogenesis and Anti-Angiogenic Therapy in Gastric Cancer.Effective Treatment of Cytotoxic Agent Refractory Alpha-Fetoprotein-Producing Gastric Cancer with Ramucirumab: a Case Report and Review of the Literature.Reduced serum vascular endothelial growth factor receptor-2 (sVEGFR-2) and sVEGFR-1 levels in gastric cancer patients.

P2860

Q30239109-6C6A23C9-B74A-47D7-AB4C-9BB7C5CA0A85 Q33712400-CF68FDB3-958A-4695-B815-5FC3C8B1FD42 Q33759177-F6706ED7-6C52-4133-B200-31E3A4AA9AC3 Q34019881-E43EAAEF-F979-4942-BE92-955BC3F00AB9 Q34686222-41756AF0-3A68-4E30-BF8D-47A0C9E30529 Q35402268-C491A38C-7052-47FD-9EE8-DD245500263E Q37135278-82F758A7-A646-46AF-BEF8-882E3B139867 Q37269631-1E9A09C2-A5E5-40DD-B85A-2E4918E6FC83 Q37290826-E59C384B-6412-4BB0-8AF2-284DE53835AF Q37351778-CD39B855-D4CC-48B6-B33B-EFDE7AAC11FB Q37454494-BF0CF08C-94A4-459E-A3D1-7A15B0BFB004 Q37578707-39FB4ECC-5568-40EC-B36D-AB90F1E74745 Q37686184-F1505903-5C56-4E4F-93C3-7039845411D5 Q38140678-84532ED8-6C3A-4FEE-BBEE-521508D4A522 Q38272318-09886F44-5BCA-4D4E-82B1-7A3F290E8733 Q38578404-B25F88D9-C50A-44F1-A46E-43EF76E0A997 Q38880712-225C7ACC-A481-48A5-BBD3-4BFF9890978C Q38962430-AB6E33D1-BFE9-4E54-B6BA-2E12CC4C5976 Q39038881-25A05430-8F72-4516-9BED-75FDE1617A89 Q39171565-8A44BCD4-3AA2-4FF7-AA8B-4781801E5407 Q39502736-76751817-D060-408B-9CDE-8FE368828D52 Q42153359-95051DB2-22E5-4364-A8B0-1B86EDE75EAB Q42265610-126A2DE7-9416-40B9-9478-F3417CA061E2 Q42984756-630D6A89-A6C0-4CE0-8DE5-8CA277CCE3CF Q47218543-847EAFE5-5DF6-49BB-9F30-D13108957511 Q49693392-59FF32AB-BFA0-4ED9-ABD2-AFFA1E85FCBB Q54621257-AB706B70-6333-436B-854C-5685B4C0EA82

P2860

Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer.

http://www.wikidata.org/entity/Q33331462

description

2008 nî lūn-bûn

@nan

2008 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Clinicopathologic significance ...... VEGF level in gastric cancer.

@ast

Clinicopathologic significance ...... VEGF level in gastric cancer.

@en

Clinicopathologic significance ...... VEGF level in gastric cancer.

@nl

type

label

Clinicopathologic significance ...... VEGF level in gastric cancer.

@ast

Clinicopathologic significance ...... VEGF level in gastric cancer.

@en

Clinicopathologic significance ...... VEGF level in gastric cancer.

@nl

prefLabel

Clinicopathologic significance ...... VEGF level in gastric cancer.

@ast

Clinicopathologic significance ...... VEGF level in gastric cancer.

@en

Clinicopathologic significance ...... VEGF level in gastric cancer.

@nl

P1433

Q33331462-A75DA788-0841-408B-9ECE-3CAA1DBBAB2D

P1476

Q33331462-B7996DAD-F11E-4B92-B581-588F38FEED28

P2093

Q33331462-0C9C6738-BC62-4F74-9A3D-BBE39205989F

Q33331462-16714B72-1EAC-409C-B94A-7B27015976FE

Q33331462-2FB94C89-FCE8-48C1-9FC1-08799A9A65D5

Q33331462-30728F1C-FB7E-41FC-859F-245C3AEAE1DE

Q33331462-32A30A46-EBB5-4301-8FAC-D7F4F5041676

Q33331462-54F936F6-EB88-4B03-A339-398245998C3D

Q33331462-8CC6EF9A-B326-44E8-B44C-222E08282E8C

Q33331462-A843B917-028F-4808-ACD5-D4406A32B671

Q33331462-AAADC6FE-7FBD-4B1D-B2A2-B5D7B47370C5

Q33331462-D2B95CF8-35E2-4C31-A811-DAA79E0DF7E7

P2860

Q33331462-0808FD82-BEFC-4A14-BF7E-61879444893E

Q33331462-0DC62F01-DBBA-4C97-831C-D6E6A10ED87D

Q33331462-1263DC14-905C-49EF-8F0F-3A7457551D25

Q33331462-1925D705-99C3-4E52-A9CC-74199DC99E99

Q33331462-1EE80D1E-D4C3-4DE7-B93D-3CE49AD3C18B

Q33331462-2617D94C-593B-4C50-AA58-D07DF6429AEE

Q33331462-2A86F805-A919-4367-AFF7-10694251AA70

Q33331462-3C110A42-5EF0-40FE-90AA-B35C881C35F2

Q33331462-3EF5152C-7E4C-4B0B-9636-64D91E546896

Q33331462-4EFE38F2-C98E-4C5E-B1FC-3574D0D97CE9

P2888

Q33331462-B2D219D9-A3D2-4B60-B5EB-32A607AB2318

P304

Q33331462-8C141020-4E01-4854-968F-296FD0229517

P31

Q33331462-D97B28CD-1BC6-4F88-B9ED-D2702E3ABB73

P356

Q33331462-3AEC86B2-0C45-4A3C-B383-C1F624F02E88

P407

Q33331462-7DAC6BDE-1486-4858-80D5-74C9BEFD83A2

P478

Q33331462-6337FF99-B4DE-40CC-B00D-337822945294

P577

Q33331462-B0358C5A-3A32-4CEF-91DF-6F64B4B0C63B

P5875

Q33331462-DAA1FD7C-5450-4E85-833D-64485D924CB8

P6179

Q33331462-73B92BBD-D2DA-4866-9799-C6C0F122157B

P698

Q33331462-A26ABC07-A460-4AB5-81FE-D84FBA53B343

P932

Q33331462-693E85DB-566B-455C-80EA-DD0D49A8873C

P356

1471-2407-8-123

P1433

P1476

Clinicopathologic significance ...... VEGF level in gastric cancer.

@en

P2093

Chung Ock Kim

http://www.w3.org/2001/XMLSchema#string

Hyo-Jin Kim

http://www.w3.org/2001/XMLSchema#string

Hyuk-Chan Kwon

http://www.w3.org/2001/XMLSchema#string

Jin Seok Jang

http://www.w3.org/2001/XMLSchema#string

Jin-Yeong Han

http://www.w3.org/2001/XMLSchema#string

Jin-sook Jeong

http://www.w3.org/2001/XMLSchema#string

Kyeong Hee Kim

http://www.w3.org/2001/XMLSchema#string

Min Chan Kim

http://www.w3.org/2001/XMLSchema#string

Su-Jin Kim

http://www.w3.org/2001/XMLSchema#string

Sung Yong Oh

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression

Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis

Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy

Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer

Expression of hypoxia-inducible factor 1? in brain tumors

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

Clinical implications of circulating angiogenic factors in cancer patients.

Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells.

Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth.

Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status.

P2888

1471-2407-8-123

P304

123

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-8-123

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5399347

http://www.w3.org/2001/XMLSchema#string

P6179

1013053329

http://www.w3.org/2001/XMLSchema#string

P698

18452596

http://www.w3.org/2001/XMLSchema#string

P932

2397429

http://www.w3.org/2001/XMLSchema#string